Alecensa 150 MG capsule UU 240S
Ended Awarded
- Contract number
- SPE2DX25F6ADB
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $38,347
Award facts
- Contract value 100% obligated
- $38,346.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $38,346.96 on August 12, 2025, for 240 units of Alecensa 150 mg capsules. The contract, which carries an ultimate completion date of September 3, 2025, is issued without a set-aside designation and is funded through the Defense Logistics Agency's Medical Supply Chain division. This delivery order falls under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products to support military healthcare facilities nationwide.
Alecensa is a branded oncology medication used in the treatment of non-small cell lung cancer, consistent with DMS Pharmaceutical Group's established portfolio of specialty pharmaceutical distributions to federal healthcare systems. The company's role as a critical supplier within the Defense Logistics Agency's pharmaceutical supply chain reflects its consistent performance in delivering prescription medications, biologics, and medical consumables to Department of Defense healthcare sites. This delivery order represents a routine procurement action within the established indefinite delivery contract framework that governs DMS Pharmaceutical Group's ongoing pharmaceutical supply relationship with the federal government.
Quick answers
Who was awarded contract SPE2DX25F6ADB?
SPE2DX25F6ADB was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on August 12, 2025.
How much is contract SPE2DX25F6ADB worth?
The government has obligated $38,347 on SPE2DX25F6ADB.
Is contract SPE2DX25F6ADB an order under another contract?
Yes. SPE2DX25F6ADB is a delivery order under SPE2DX15D9114, an indefinite delivery contract.
Was contract SPE2DX25F6ADB competed?
The extent of competition for SPE2DX25F6ADB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award